People · Operator

Imran Chaudhri

Named in public records as an officer, director or promoter · active 2009–2012 · Other Technology

1
Companies
4
Filings
$46.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Apixio Inc.Other TechnologySeries B$46.7M$152.3M2009
Operator network

Imran Chaudhri at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Jared Kesselheim · 7 companies · 1 sharedJared KesselheimJames Bradley · 6 companies · 1 sharedJames BradleyERIC SHUEY · 4 companies · 1 sharedERIC SHUEYCasey West · 3 companies · 1 sharedCasey WestShahin Hedayat · 3 companies · 1 sharedShahin HedayatFarzad Nazem · 2 companies · 1 sharedFarzad NazemPetro Estakhri · 2 companies · 1 sharedPetro EstakhriDarren Schulte · 1 companies · 1 sharedDarren SchulteFarzad Shawn Nazem · 1 companies · 1 sharedFarzad Shawn NazemImran Chaudri · 1 companies · 1 sharedImran ChaudriJeff Harmon · 1 companies · 1 sharedJeff HarmonJoel Portice · 1 companies · 1 sharedJoel PorticeSachin Patel · 1 companies · 1 sharedSachin PatelShahram Dastmalchi · 1 companies · 1 sharedShahram DastmalchiShahram Shawn Dastmalchi · 1 companies · 1 sharedShahram Shawn Das…Apixio Inc. · $46.7M raisedApixio Inc.Imran ChaudhriIC
Imran Chaudhri Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Imran Chaudhri on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jared Kesselheim17
James Bradley16
ERIC SHUEY14
Casey West13
Shahin Hedayat13
Farzad Nazem12
Petro Estakhri12
Joel Portice11
Sachin Patel11
Shahram Shawn Dastmalchi11
Farzad Shawn Nazem11
Imran Chaudri11
Shahram Dastmalchi11
Darren Schulte11
Jeff Harmon11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.